Supernus Pharmaceuticals to Host Webcast to Review Interim D

Supernus Pharmaceuticals to Host Webcast to Review Interim Data from Ongoing Open-Label Phase IIa Study of SPN-817 for Treatment-Resistant Seizures

Supernus Pharmaceuticals to Host Webcast to Review Interim Data from Ongoing Open-Label Phase IIa Study of SPN-817 for Treatment-Resistant Seizures

tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Timothyc Dec , Peter Vozzo , Jacka Khattar , Exchange Commission , Supernus Pharmaceuticals , Company Investor Relations , Nasdaq , Supernus Pharmaceuticals Inc , Securities Exchange , Host Webcast , Review Interim Data , Ongoing Open Label Phase , Investor Relations , Private Securities Litigation Reform Act , Securities Exchange Act , Senior Vice President ,